Lymph Node Harvest in Dukes' A Cancer Pathologist May Need to Consider Fat Dissolving Technique: An Observational Study by Saklani, A. P. et al.
The Scientiﬁc World Journal
Volume 2012, Article ID 919464, 3 pages
doi:10.1100/2012/919464 The  cientiﬁcWorldJOURNAL
Clinical Study
LymphNodeHarvest inDukes’ACancerPathologist May Needto
Consider Fat Dissolving Technique: An Observational Study
A.P. Saklani,1,2 T. Udy,1 T. V.Chandrasekaran,1 M.Davies,1 andJ. Beynon1
1Department of Colorectal Surgery, Abertawe Bro Morgannwg University Hospital Trust, Singleton Hospital, Swansea SA2 8QA, UK
2Department of Colorectal Surgery, Abertawe Bro Morgannwg University Hospital Trust, Princess of Wales Hospital,
Bridgend CF31 1RQ, UK
Correspondence should be addressed to A. P. Saklani, avanish.saklani@wales.nhs.uk
Received 12 October 2011; Accepted 5 December 2011
Academic Editor: Toshio Uraoka
Copyright © 2012 A. P. Saklani et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background.Nationalinstituteofclinicalexcellence(NICE)recommendsthatamedianof12lymphnodesbeexaminedinpatients
operated on with curative intent- to- treat colorectal cancer (CRC). Patients with lymph node harvest less than this may be consid-
ered under staged and may receive adjuvant chemotherapy. The aim of our study was to ascertain median number of lymph nodes
examined in early colorectal cancers. Method. Patients undergoing colorectal resection between June 2007 and May 2008 were
identiﬁed and pathological staging obtained using pathology database. Results. 146 patients underwent standardised laparoscopic
oropenresectionofcolorectalcancersduringthisperiod.Overallmediannumberoflymphnodesharvested/patientwas14(3–40).
When analysed by stage, median number of lymph nodes harvested in Dukes’ A, B, and C cancers was 10, 14, and 15, respectively.
11/18 (61%) patients with Dukes’ A carcinoma had lymph node harvest of less than 12 compared with 15/55 (27%) patients with
Dukes’ B. Conclusion. Lymph node harvest in Dukes’ A cancers using standard techniques tends to be low. Pathologists may have
to consider special techniques in harvesting lymph nodes for early colorectal cancers.
1.Background
National institute of clinical excellence (NICE) Colorectal
Cancer Guidance and the American Joint Committee on
Cancer (AJCC) have recommended that a median of 12
lymph nodes should be examined in patients operated on
with curative intent-to-treat colorectal cancer (CRC). A
lymph node harvest of less than 12 will be considered below
recommended standard and may lead to administration of
adjuvant chemotherapy.
2. Aim
Toassessthenumberoflymphnodesexaminedandreported
in Dukes’ A and Dukes’ B carcinoma in regional cancer
centre.
3. Method
Patientsundergoingcolorectalresection(onlyadenocarcino-
mas) with curative intent between June, 2007 and May, 2008
were identiﬁed. Squamous carcinomas of rectum and car-
cinoids were excluded, as adjuvant therapy after surgery in
these cancers is not standardised. Like most centres in UK,
majority of resections were performed open in 2007-2008, as
laparoscopic colorectal surgery was being established in our
unit. The pathology records of these patients was analysed
retrospectively to assess the Dukes’ stage and the number of
lymph nodes harvested.
4. Results
146 patients underwent potentially curative resection for
colorectal cancers (adenocarcinomas) during this period,
Dukes’ A 18, Dukes’ B 55, and Dukes’ C 73. During this peri-
od, 8.5% of all resections were laparoscopic assisted. Median
number of lymph nodes harvested was 14 (3–40).
Median number of lymph nodes as per stage was Dukes’
A10.5(3–26),B14(4–40),andC15(5–32)Table 1.Similarly
median number of lymph node harvested and lymph node
metastasis as per T stage was assessed (Table 2).2 The Scientiﬁc World Journal
Table 1: Relation of number of lymph node harvested to Duke’s
Stage.
Duke’s A Duke’s B Duke’s C
No of patients (%) 18 (12.3%) 55 (37.7%) 73 (50%)
Median no lymph nodes
harvested
10.5 14 15
Range of lymph node
harvested
3–26 4–40 5–32
Table 2: Relation of lymph node metastasis and T stage.
T1 T2 T3 T4
No of patients (%) 14
(9.6%)
10
(6.8%)
91
(62.3%)
31
(21.2%)
Median no lymph nodes
harvested 11.5 11.0 15 17
Metastatic lymph node (%) 3/14
(21%)
3/10
(30%)
44/91
(48%)
23/31
(74%)
11/18 (61%) patients with Dukes’ A carcinoma had
lymph node harvest of less than 12 compared with 15/55
(27%) patients with Dukes’ B. (P<0.05). See Table 3.
6 patients with rectal cancer underwent preoperative
chemoradiotherapy. Even if these patients were excluded,
10/16 (62.5%) patients with Dukes’ A carcinoma had lymph
node harvest of less than 12 compared with 13/51 (25.4%)
patients with Dukes’ B. (P<0.05). See Table 4.
5. Discussion
In the national bowel cancer audit project (NBOCAP),
10.5% of all colorectal cancers were diagnosed to be Dukes’
Ac a n c e r[ 1]. National bowel cancer screening aims to detect
Colorectal cancers at an earlier stage and bring about 15%
reduction in mortality due to CRC. In Nottingham, popula-
tion based screening, in the ﬁrst round of screening 46% of
detected cancers were Dukes’ A [2].
At present adjuvant chemotherapy is oﬀered to all pa-
tients with Dukes’ C cancer as it reduces the recurrence rate
by 41% and the death rate by 33% [3]. In patients with
Dukes’ B cancer, adjuvant chemotherapy oﬀers 3.6% abso-
lute improvement in survival, hence adjuvant chemotherapy
is oﬀered to selected patients with poor prognostic factors
[4].
Staging of CRC is based on identiﬁcation of lymph node
metastasis, which in turn would depend on lymph node har-
vest and their identiﬁcation by pathologists. Numerous stud-
ies have shown, patients with Dukes B cancer with lymph
node harvest less than 8 or 9 have survival equivalent to
Dukes’ C cancer, suggesting under staging of cancer due to
inadequate lymph node harvest [5–7].
In patients with colon cancer who are treated with cura-
tive intent, 12 or more nodes should normally be examined;
if the median number is consistently below 12, the surgeon
and the histopathologist should discuss their techniques [8].
In fact, in one recent study, lymph node harvest in a unit
Table 3: Corelation between lymph node harvest and Dukes’ stage.
All patients Lymph node
harvest < 12
Lymph node
harvest ≥ 12
Total
Dukes’ A 11 7 18
Dukes’ B 15 40 55
Total 26 47 73
Table 4: Corelation between lymph node harvest and Dukes’ stage
(6 patients undergoing radiotherapy excluded).
Patients undergoing
Radiotherapy excluded
Lymph node
harvest < 12
Lymph node
harvest ≥ 12
Total
Dukes’ A 10 6 16
Dukes’ B 13 38 51
Total 23 44 67
varied according to the reporting pathologist but not the
operating surgeon [9].
Various societies, namely, ACPGBI, SAGES have recom-
mended minimum of lymph node harvest to be 12 as quality
indicator of surgery. Patients with lymph node harvest less
than 12 may be an indicator of inadequate sampling and pa-
tients may be oﬀered chemotherapy. While this may be
appropriate for Dukes’ B (T3 and T4 cancers), where inci-
dence of lymph node harvest and metastasis is higher, anal-
ogy of this to T1/T2 cancers may not be appropriate where
lymph node metastasis rate is low [10, 11]. In our study,
incidence of lymph node metastasis in T1 (21%) and T2
(30%) cancers was higher than reported, but absolute num-
bers are low.
Our study shows median number of lymph node harvest
for Dukes’ A cancers was 10.5 in fact, if this was taken as
inadequate sampling, 62% patients with Dukes’ A cancer
would have been oﬀered chemotherapy. In reality, only one
patient with Dukes’ A received chemotherapy as a result of
inadequate lymph node harvest. While the absolute number
of patients with Dukes’ A is about 18 (12.3%). This number
is bound to increase to 46% of all cancers once screening gets
underway [2].
In the 1997, TNM classiﬁcation, of both the American
Joint Committee on Cancer (AJCC) and the International
Union Against Cancer (UICC), surgery for colorectal cancer
in UK is standardised, where histological examination would
ordinarily include 12 (for colorectal carcinoma) or more
lymph nodes. A communication later by UICC and AJCC re-
garding the same cautioned against classifying less than 12
lymph nodes as Pnx. They clariﬁed that the above statement
was not intended to be a requirement for pNo but rather a
guideline [12].
While the surgical resection for right hemicolectomy in
UK remains standard. We can, however, improve on patho-
logical assessment of lymph nodes. While we do agree most
pathologists diligently do lymph node identiﬁcation, special
techniques to identify lymph nodes in T1/T2 cancer may
be required. Special techniques like fat dissolving technique
have been shown in many studies to improve lymph nodeThe Scientiﬁc World Journal 3
harvest [12]. We suggest these techniques be used to improve
lymph node identiﬁcation in Dukes A cancer (T1/T2) can-
cers, where lymph node harvest was less than 12.
6. Conclusion
Lymph node harvest in Dukes’ A cancer tends to be low.
Pathologist may have to consider specialised techniques like
fat dissolution to harvest more lymph nodes in Dukes A
(T1/T2 cancers), where lymph node harvest is less than 12.
This will assume importance as National screening pro-
gramme will identify more early colorectal cancers.
References
[1] CSCG Bowel Cancer Report 2005-07.
[2] J. D. Hardcastle, J. O. Chamberlain, M. H. E. Robinson et al.,
“Randomised controlled trial of faecal-occult-blood screening
for colorectal cancer,” Lancet, vol. 348, no. 9040, pp. 1472–
1477, 1996.
[ 3 ]C .G .M o e r t e l ,T .R .F l e m i n g ,J .S .M a c d o n a l de ta l . ,“ F l u -
orouracil plus levamisole as eﬀective adjuvant therapy after
resection of stage III colon carcinoma: a ﬁnal report,” Annals
of Internal Medicine, vol. 122, no. 5, pp. 321–326, 1995.
[4] R. Gray, J. Barnwell, C. McConkey, R. K. Hills, N. S. Williams,
and D. J. Kerr, “Adjuvant chemotherapy versus observation in
patients with colorectal cancer: a randomised study,” Lancet,
vol. 370, no. 9604, pp. 2020–2029, 2007.
[5] F. Cianchi, A. Palomba, V. Boddi et al., “Lymph node recovery
fromcolorectaltumorspecimens:recommendationforamin-
imumnumberoflymphnodestobeexamined,”World Journal
of Surgery, vol. 26, no. 3, pp. 384–389, 2002.
[ 6 ]T .E .L eV o y e r ,E .R .S i g u r d s o n ,A .L .H a n l o ne ta l . ,“ C o l o n
cancer survival is associated with increasing number of lymph
nodes analyzed: a secondary survey of intergroup trial INT-
0089,” Journal of Clinical Oncology, vol. 21, no. 15, pp. 2912–
2919, 2003.
[7] K. Yoshimatsu, K. Ishibashi, A. Umehara et al., “How many
lymph nodes should be examined in Dukes’ B colorectal can-
cer? Determination on the basis of cumulative survival rate,”
Hepato-Gastroenterology, vol. 52, no. 66, pp. 1703–1706, 2005.
[8] NICE Improving Outcomes in Colorectal Cancer. Manual Up-
date, National Institute for Clinical Excellence, London, UK,
2004.
[ 9 ]M .D .E v a n s ,K .B a r t o n ,A .R e e s ,J .D .S t a m a t a k i s ,a n dS .S .
Karandikar,“Theimpactofsurgeonandpathologistonlymph
node retrieval in colorectal cancer and its impact on survival
for patients with Dukes’ stage B disease,” Colorectal Disease,
vol. 10, no. 2, pp. 157–164, 2008.
[10] R. Nascimbeni, L. J. Burgart, S. Nivatvongs, and D. R. Larson,
“Risk of lymph node metastasis in T1 carcinoma of the colon
and rectum,” Diseases of the Colon and Rectum,v o l .4 5 ,n o .2 ,
pp. 200–206, 2002.
[11] S. P. J. Huddy, E. M. Husband, M. G. Cook, N. M. Gibbs, C.
G. Marks, and R. J. Heald, “Lymph node metastases in early
rectal cancer,” British Journal of Surgery, vol. 80, no. 11, pp.
1457–1458, 1993.
[12] L.H.SobinandF.L.Greene,“TNMclassiﬁcation:clariﬁcation
of number of regional lymph nodes for pNO,” Cancer, vol. 92,
no. 2, p. 452, 2001.